Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.3  +
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.1  +
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.6  +
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 6.1  +
• Reference:EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - Organisation  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 49  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-002  +
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 62 Paragraph 4  +
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 72  +
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 68  +
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 5-002  +
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 7 – 8  +
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 1.12  +
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-001  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 3 Absatz 5 – 6  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 30-002  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 62-001  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 65  +
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (viii)  +
• Reference:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. A.  +